UBE2QL1 and renal cell carcinoma: We therefore investigated whether UBE2QL1 promoter hypermethylation was present in primary RCC and we detected hypermethylation in 14/66 (21.2%) primary RCC tested (but not in matched normal kidney where available) (Fig. 2C and D).